Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Investment Counsel's AMGN Position: Q1 2021 in Review
Investment Counsel reduced its Amgen (AMGN) stake by 7.1% in Q1 2021, selling an estimated $131K and leaving 7,151 shares worth $1.78M. The position accounts for 1.25% of the portfolio, ranked #25.
Investment Counsel first reported a position in AMGN in Q2 2016 and has held it in 20 quarters since. The position peaked at $1.92M in Q3 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.
- Investment Counsel held 7,151 shares of Amgen worth $1.78M as of Q1 2021.
- Investment Counsel sold 550 Amgen shares in Q1 2021, an estimated $131K.
- Amgen made up 1.25% of Investment Counsel's portfolio in Q1 2021, its #25 holding.
- Investment Counsel first reported a position in Amgen in Q2 2016 and has held it in 20 quarters since.
- Investment Counsel's Amgen position peaked at $1.92M in Q3 2020.
- 2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.
Based on Investment Counsel's 13F filing for Q1 2021, filed 12 Apr 2021.